Assertio Therapeutics, Inc.
Bayanan rajista na hukuma
0masu bi
2018an kafa
Game da Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.
Source: Wikipedia
Hedikwata251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
An kafa2018
MatsayiMai aiki
Haƙƙoƙin ƙirƙira1 haƙƙin ƙirƙira
GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF CNS DISORDERSEP2326310B1 · 2019
Bitoci
Babu bitoci tukuna. Ka yi aiki da Assertio Therapeutics, Inc.? Kasance na farko da zai raba gogewarsa.
Bayanan doka
| Sunan doka | Assertio Therapeutics, Inc. |
|---|---|
| LEI | 549300L2A9NTF1JVDP20Duba a GLEIF ↗ |
| Adireshin da aka yi rajista | 251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US |
| Matsayi | Mai aiki |
Tushe: GLEIF · an sabunta Oct. 16, 2026
Tuntuɓa & hanyoyin haɗi
Wuri
251 LITTLE FALLS DRIVE, 19808, WILMINGTON, US
Wannan kamfaninka ne?
Yi da'awar wannan shafi kyauta don ƙara tambari, kayayyaki, hotuna da ayyuka, da amsa bitoci.
Yi da'awar wannan shafiShiga Heelky don haɗuwa, ɗaukar ma'aikata da haɓaka
Ƙirƙiri asusu kyauta don aika wa mutane saƙo, neman ayyuka da wallafa kwangiloli.
Shiga yanzu — kyauta ne